SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-20-006213
Filing Date
2020-03-26
Accepted
2020-03-26 16:12:08
Documents
104
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K nby20191231_10k.htm 10-K 2237925
2 EXHIBIT 23 ex_178412.htm EX-23 2677
3 EXHIBIT 31.1 ex_177280.htm EX-31.1 8554
4 EXHIBIT 31.2 ex_177279.htm EX-31.2 8873
5 EXHIBIT 32.1 ex_177278.htm EX-32.1 4562
6 EXHIBIT 32.2 ex_177277.htm EX-32.2 4193
13 nby20191231_10kimg001.gif GRAPHIC 18698
  Complete submission text file 0001437749-20-006213.txt   12343715

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT nby-20191231.xml EX-101.INS 2843928
8 XBRL TAXONOMY EXTENSION SCHEMA nby-20191231.xsd EX-101.SCH 122471
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20191231_cal.xml EX-101.CAL 73890
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20191231_def.xml EX-101.DEF 773505
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20191231_lab.xml EX-101.LAB 663259
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20191231_pre.xml EX-101.PRE 822522
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33678 | Film No.: 20746274
SIC: 2834 Pharmaceutical Preparations